PROPANC BIOPHARMA, INC. Debt Instrument, Increase (Decrease), Other, Net
PROPANC BIOPHARMA, INC. (PPCB) reported Debt Instrument, Increase (Decrease), Other, Net of $105.00 thousand for the 6-month period ending 2016-12-31, per its 10-Q filed 2017-02-14.
Discontinued › Notes › Debt Instruments › Debt Instrument, Increase (Decrease), Net
us-gaap:DebtInstrumentIncreaseDecreaseOtherNet · last filed 2017-02-14
- PROPANC BIOPHARMA, INC. debt instrument, increase (decrease), other, net for the quarter ending 2016-06-30 was $0.00.
- PROPANC BIOPHARMA, INC. debt instrument, increase (decrease), other, net for fiscal 2016 was $50.00K.
| Period end | Debt Instrument, Increase (Decrease), Other, Net 3 month | Debt Instrument, Increase (Decrease), Other, Net 6 month | Debt Instrument, Increase (Decrease), Other, Net 9 month | Debt Instrument, Increase (Decrease), Other, Net 12 month |
|---|---|---|---|---|
| 2016-12-31 | $105.00K 10-Q · filed 2017-02-14 | |||
| 2016-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-28 | $50.00K 10-K · filed 2016-09-28 | ||
| 2016-03-31 | $50.00K 10-Q · filed 2016-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |